Form D · Biotechnology

LumeNXT LLC

Knoxville, TN · CIK 0001895649

Offering snapshot reported Nov 30, 2021 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
14
Form D · investor count
Minimum accepted
$75K
Reported outside-investor minimum
First sale
Nov 19, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$750K$1.5MNov 29, 2021: $1,500,001.00Nov 29, 2021Nov 30, 2021: $1,500,001.00Nov 30, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 30, 2021Amendment$1,500,001$0vs Nov 29, 202114SEC filing
Nov 29, 2021Initial$1,500,001No comparison14SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-422786
The total amount remaining to be sold is $0.00

Source: Form D, filed Nov 30, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Beer Director
Michael Christopher Doody Director, Executive
Robin Horell Director
Mickey Karram Director
Matthew Langenderfer Director
Joshua Murphey Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3665 Iskagna Dr.
Knoxville, TN, 37919